System; Lupus Erythematosus Clinical Trial
Official title:
Individual Patient Expanded Access IND to Evaluate the Safety and Efficacy of HB-adMSCs for the Treatment of Systemic Lupus Erythematosus (SLE)
This protocol is part of an FDA Individual Patient Expanded Access IND. This study is to be conducted according to US and International Standards of Good Clinical Practice (FDA Title 21 part 312 and International Conference on Harmonization guidelines), applicable government regulations and Hope Biosciences Stem Cell Research Foundation policies and procedures.
This Individual Patient Expanded Access IND has been created per the request of a 65-year-old woman diagnosed with Systemic Lupus Erythematosus (SLE). ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04024306 -
Steroid-induced Diabetes Mellitus in Systemic Lupus Erythematosus (SLE) Patients
|
||
Active, not recruiting |
NCT04018222 -
Translation of a Diagnostic Test for Lupus Flare Prediction From Bench to Clinic
|
||
Completed |
NCT04527172 -
Neuromuscular Ultrasonography Utility for Detection of Peripheral Neuropathy in Systemic Lupus Erythematosus
|
||
Completed |
NCT05458531 -
Monitoring of Inflammatory Conditions
|
||
Completed |
NCT04970199 -
Cardiovascular Protective Role of Laser Acupuncture in Systemic Lupus
|
N/A | |
Completed |
NCT03426384 -
FLARE Lupus Research Study Systemic Lupus Erythematosus
|
N/A | |
Recruiting |
NCT05984316 -
Systemic Lupus Erythematosus
|
N/A | |
Completed |
NCT03171194 -
Pilot Trial of Mesenchymal Stem Cells for Systemic Lupus Erythematosus
|
Phase 1 | |
Recruiting |
NCT06383104 -
Myofascial Techniques and Proprioceptive Neuromuscular Facilitation in Patients With Systemic Lupus Erythematosus.
|
N/A | |
Not yet recruiting |
NCT05314881 -
NCF Gene & TNFSF4 in SLE Patients
|
N/A |